WAYNE, Pa., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Management of Teleflex Incorporated (NYSE: TFX) will be presenting at the Morgan Stanley 23 rd Annual Global Healthcare Conference at the Sheraton New ...
Teleflex is launching new products, acquiring Biotronik’s vascular unit, and splitting into two companies to reignite growth and unlock value. Margins are strong, the balance sheet is solid, and cash ...
New, independent, publicly traded company (NewCo) consisting of Teleflex’s Urology, Acute Care, and OEM businesses. RemainCo will consist of Teleflex’s Vascular Access, Interventional, and Surgical ...
Teleflex's recent OEM contract loss is an ongoing challenge, but the company is poised to benefit from IABP market share gains and other strategic initiatives. As of now, there is no certainty that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback